These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 29943738)
21. Measles-rubella mass immunization campaign in Albania, November 2000. Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917 [TBL] [Abstract][Full Text] [Related]
22. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207 [TBL] [Abstract][Full Text] [Related]
23. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland. Paunio M; Virtanen M; Peltola H; Cantell K; Paunio P; Valle M; Karanko V; Heinonen OP Am J Epidemiol; 1991 Jun; 133(11):1152-60. PubMed ID: 2035518 [TBL] [Abstract][Full Text] [Related]
24. Progress in measles and rubella elimination in Iran. Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452 [TBL] [Abstract][Full Text] [Related]
25. Cost of conducting Measles-Rubella vaccination campaign in India. Chatterjee S; Song D; Das P; Haldar P; Ray A; Brenzel L; Boonstoppel L; Mogasale V Hum Vaccin Immunother; 2022 Dec; 18(1):1-8. PubMed ID: 34411494 [TBL] [Abstract][Full Text] [Related]
26. Communication lessons learned from the 2017 measles-rubella campaign in India: perspectives from vaccine decision-makers. Limaye RJ; Gupta M; Bansal A; Chandler MK; Santosham M; Erchick DJ Health Promot Int; 2022 Oct; 37(5):. PubMed ID: 36287519 [TBL] [Abstract][Full Text] [Related]
28. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study. Bae GR; Choe YJ; Go UY; Kim YI; Lee JK Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654 [TBL] [Abstract][Full Text] [Related]
29. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008. Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269 [TBL] [Abstract][Full Text] [Related]
30. Addressing issues of vaccination literacy and psychological empowerment in the measles-mumps-rubella (MMR) vaccination decision-making: a qualitative study. Fadda M; Depping MK; Schulz PJ BMC Public Health; 2015 Sep; 15():836. PubMed ID: 26328551 [TBL] [Abstract][Full Text] [Related]
31. Measuring vaccine acceptance among Canadian parents: A survey of the Canadian Immunization Research Network. Dubé E; Gagnon D; Ouakki M; Bettinger JA; Witteman HO; MacDonald S; Fisher W; Saini V; Greyson D; Vaccine; 2018 Jan; 36(4):545-552. PubMed ID: 29233605 [TBL] [Abstract][Full Text] [Related]
32. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination. Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586 [TBL] [Abstract][Full Text] [Related]
33. Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh. Khan AI; Islam MT; Siddique SA; Ahmed S; Sheikh N; Siddik AU; Islam MS; Qadri F Hum Vaccin Immunother; 2019; 15(12):2882-2886. PubMed ID: 31441679 [No Abstract] [Full Text] [Related]
34. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination. Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256 [TBL] [Abstract][Full Text] [Related]
36. The measles/rubella immunisation campaign in Scotland. Skinner R; Christie P; Cowden JM Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234 [TBL] [Abstract][Full Text] [Related]
37. [Measles, mumps and rubella vaccination status of school beginners in Munich]. Markuzzi A; Schlipköter U; Weitkunat R; Meyer G Soz Praventivmed; 1997; 42(3):133-43. PubMed ID: 9334085 [TBL] [Abstract][Full Text] [Related]
38. Associations between health communication behaviors, neighborhood social capital, vaccine knowledge, and parents' H1N1 vaccination of their children. Jung M; Lin L; Viswanath K Vaccine; 2013 Oct; 31(42):4860-6. PubMed ID: 23954379 [TBL] [Abstract][Full Text] [Related]
39. Measles immunization of 2-year-olds in a rural southern state. Feldman S; Andrew M; Gilbert J; Bracken B; Thompson FE JAMA; 1994 May; 271(18):1417-20. PubMed ID: 8176803 [TBL] [Abstract][Full Text] [Related]
40. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate. Pareek M; Pattison HM Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]